Cargando…

The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study

Whether number of examed lymph nodes (ELNs) would bring survival benefit for patients with negative lymph nodes after modified radical mastectomy (MRM) is uncertain. In our study, using the Surveillance Epidemiology and End Results (SEER) database between 2004 and 2009, we screened the appropriate p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Huiying, Zhang, Chenyue, Wang, Haiyong, Wang, Zhehai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630362/
https://www.ncbi.nlm.nih.gov/pubmed/29029462
http://dx.doi.org/10.18632/oncotarget.20052
_version_ 1783269208909414400
author Chi, Huiying
Zhang, Chenyue
Wang, Haiyong
Wang, Zhehai
author_facet Chi, Huiying
Zhang, Chenyue
Wang, Haiyong
Wang, Zhehai
author_sort Chi, Huiying
collection PubMed
description Whether number of examed lymph nodes (ELNs) would bring survival benefit for patients with negative lymph nodes after modified radical mastectomy (MRM) is uncertain. In our study, using the Surveillance Epidemiology and End Results (SEER) database between 2004 and 2009, we screened the appropriate patients with negative lymph nodes underwent MRM. The Cox proportional hazard analysis was used to determine the effect of number of ELNs on cancer specific survival (CSS). The results showed that the number of ELNs was not an independent prognostic factor on CSS (P = 0.940). Then the X-tile mode was used to determine the appropriate threshold for ELNs count. The results showed that 9 was the appropriate cut-off point. Next, the log-rank χ(2) test was used to analyze the CSS based on different subgroup variables. The results showed that some subgroup variables including age < 50/ ≥ 50, grade I/III, AJCC T1/T2, ER positive/negative and PR positive/negative ,demonstrated significant CSS benefits among the patients with the number of ELNs ≤ 9 (all, P < 0.05). However, three subgroup variables including grade II, AJCC T3 and AJCC T4, the patients with the number of ELNs ≤ 9 did not bring significant CSS benefits (all, P > 0.1). In conclusion, our study demonstrated that the number of ELNs was not an independent prognostic factor on CSS, and 9 can be selected as the appropriate cut-off point of ELNs for patients with negative lymph nodes who underwent MRM.
format Online
Article
Text
id pubmed-5630362
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56303622017-10-12 The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study Chi, Huiying Zhang, Chenyue Wang, Haiyong Wang, Zhehai Oncotarget Research Paper Whether number of examed lymph nodes (ELNs) would bring survival benefit for patients with negative lymph nodes after modified radical mastectomy (MRM) is uncertain. In our study, using the Surveillance Epidemiology and End Results (SEER) database between 2004 and 2009, we screened the appropriate patients with negative lymph nodes underwent MRM. The Cox proportional hazard analysis was used to determine the effect of number of ELNs on cancer specific survival (CSS). The results showed that the number of ELNs was not an independent prognostic factor on CSS (P = 0.940). Then the X-tile mode was used to determine the appropriate threshold for ELNs count. The results showed that 9 was the appropriate cut-off point. Next, the log-rank χ(2) test was used to analyze the CSS based on different subgroup variables. The results showed that some subgroup variables including age < 50/ ≥ 50, grade I/III, AJCC T1/T2, ER positive/negative and PR positive/negative ,demonstrated significant CSS benefits among the patients with the number of ELNs ≤ 9 (all, P < 0.05). However, three subgroup variables including grade II, AJCC T3 and AJCC T4, the patients with the number of ELNs ≤ 9 did not bring significant CSS benefits (all, P > 0.1). In conclusion, our study demonstrated that the number of ELNs was not an independent prognostic factor on CSS, and 9 can be selected as the appropriate cut-off point of ELNs for patients with negative lymph nodes who underwent MRM. Impact Journals LLC 2017-08-07 /pmc/articles/PMC5630362/ /pubmed/29029462 http://dx.doi.org/10.18632/oncotarget.20052 Text en Copyright: © 2017 Chi et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Chi, Huiying
Zhang, Chenyue
Wang, Haiyong
Wang, Zhehai
The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study
title The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study
title_full The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study
title_fullStr The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study
title_full_unstemmed The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study
title_short The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM: a population-based study
title_sort appropriate number of elns for lymph node negative breast cancer patients underwent mrm: a population-based study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630362/
https://www.ncbi.nlm.nih.gov/pubmed/29029462
http://dx.doi.org/10.18632/oncotarget.20052
work_keys_str_mv AT chihuiying theappropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy
AT zhangchenyue theappropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy
AT wanghaiyong theappropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy
AT wangzhehai theappropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy
AT chihuiying appropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy
AT zhangchenyue appropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy
AT wanghaiyong appropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy
AT wangzhehai appropriatenumberofelnsforlymphnodenegativebreastcancerpatientsunderwentmrmapopulationbasedstudy